Prasco launches generic Testim


Prasco LLC launches an authorized generic version of Auxilium Pharmaceuticals' (AUXL) Testim (testosterone gel) as a treatment for low or no testosterone in males. Auxilium will manufacture the product and continue to distribute the branded version.

Auxilium President & CEO Adrian Adams says, "While Testim has continued to represent an important portion of Auxilium's net sales, we have been proactively planning for this launch in an effort to most strategically position our product franchise to compete in the increasingly crowded and challenging Testosterone Replacement Therapy gel market."

Financial terms are not disclosed.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs